ZMYND8 is also involved in genome stability to block the cyclic GMP–AMP synthase-stimulator of interferon genes–NF-κB signaling and the subsequent interferon-β production in breast cancer cells, leading to cancer cell evasion from cytotoxic T-lymphocyte surveillance (19). Here, ZMYND8 is linked to breast cancer.